tert-butyl (2-(3-oxopiperazin-1-yl)ethyl)carbamate hydrochloride

Catalog No.: 
ACMZSW896
CAS No.: 
2891597-78-5
Molecular Formula: 
C11H22ClN3O3
Molecular Weight: 
279.77
tert-butyl (2-(3-oxopiperazin-1-yl)ethyl)carbamate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$183.00In stockInquiry
250mg97%$243.00In stockInquiry
500mg97%$405.00In stockInquiry
1g97%$608.00In stockInquiry
5g97%$2308.00In stockInquiry
10g97%$3923.00InquiryInquiry
25g97%$8631.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl (2-(3-oxopiperazin-1-yl)ethyl)carbamate hydrochloride
IUPAC Nametert-butyl (2-(3-oxopiperazin-1-yl)ethyl)carbamate hydrochloride
Molecular FormulaC11H22ClN3O3
Molecular Weight279.77
SMILESCC(C)(C)OC(=O)NCCN1CCNC(=O)C1.Cl
InChI KeyFFVJPYOAZDZMSK-UHFFFAOYSA-N
CAS No.2891597-78-5

Synthetic Route by SureRoute

1. ACMZSW896 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCXNG132 route compound structure diagram
    ACCXNG1325625-67-2In Stock
  4. Then
  5. ACMZSW896 route product structure diagram
    ACMZSW8962891597-78-5In Stock
Inquiry

2. ACMZSW896 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCXNG132 route compound structure diagram
    ACCXNG1325625-67-2In Stock
  4. Then
  5. ACMZSW896 route product structure diagram
    ACMZSW8962891597-78-5In Stock
Inquiry

3. ACMZSW896 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBWJP510 route compound structure diagram
    ACBWJP51089711-08-0
  2. Plus
  3. ACCXNG132 route compound structure diagram
    ACCXNG1325625-67-2In Stock
  4. Then
  5. ACMZSW896 route product structure diagram
    ACMZSW8962891597-78-5In Stock
Inquiry

Comments (0)